HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Valentina Nardi Selected Research

Phenobarbital (Luminal)

2/2022Intraplaque CTA characteristics as predictors of symptomatology: a semiautomated volumetric analysis.
1/2022Endarterectomy for symptomatic non-stenotic carotids: a systematic review and descriptive analysis.
1/2022Carotid Artery Plaque Calcifications: Lessons From Histopathology to Diagnostic Imaging.
1/2022Carotid artery endarterectomy in patients with symptomatic non-stenotic carotid artery disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Valentina Nardi Research Topics

Disease

31Neoplasms (Cancer)
11/2023 - 03/2012
6Leukemia
05/2024 - 01/2004
6BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
10/2012 - 01/2003
5Lymphoma (Lymphomas)
04/2022 - 10/2015
5Pathologic Constriction (Stenosis)
02/2022 - 10/2021
5Carcinoma (Carcinomatosis)
04/2020 - 01/2013
4Carotid Artery Diseases
09/2023 - 01/2021
4Myelodysplastic Syndromes (Myelodysplastic Syndrome)
01/2023 - 07/2012
4Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
01/2023 - 07/2012
3Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
01/2023 - 01/2018
3Carotid Stenosis (Carotid Artery Stenosis)
06/2022 - 01/2022
3Hemorrhage
06/2022 - 10/2021
3Atherosclerotic Plaque (Atheroma)
06/2022 - 01/2021
3Eosinophilia
01/2022 - 11/2020
3Stroke (Strokes)
01/2022 - 01/2022
2Coronary Artery Disease (Coronary Atherosclerosis)
01/2024 - 01/2022
2Atherosclerosis
01/2024 - 01/2022
2Amaurosis Fugax
09/2023 - 01/2022
2Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2023 - 01/2018
2Philadelphia Chromosome
01/2022 - 01/2020
2Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
01/2021 - 03/2017
2Seizures (Absence Seizure)
12/2020 - 02/2019
2Sarcoma (Soft Tissue Sarcoma)
11/2020 - 11/2017
2Thymoma (Thymic Carcinoma)
01/2020 - 01/2020
2Cholangiocarcinoma
01/2017 - 09/2015
2Parasitic Diseases (Parasitic Disease)
12/2015 - 07/2013
1Myeloid Sarcoma (Chloroma)
05/2024
1Sepsis (Septicemia)
12/2023
1Purpura Fulminans
12/2023
1Ischemic Stroke
09/2023
1Lung Neoplasms (Lung Cancer)
01/2023
1Melanoma (Melanoma, Malignant)
12/2022
1B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
10/2022
1Hematologic Neoplasms (Hematological Malignancy)
04/2022
1Neurologic Manifestations (Neurological Manifestations)
02/2022
1Cardiovascular Diseases (Cardiovascular Disease)
01/2022
1Disease Progression
01/2022
1Vascular Calcification
01/2022
1Transient Ischemic Attack
01/2022
1Confusion (Bewilderment)
12/2021
1Glioblastoma (Glioblastoma Multiforme)
11/2021
1Adenocarcinoma
08/2021
1Esophageal Squamous Cell Carcinoma
08/2021
1Bone Cysts (Bone Cyst)
05/2021
1Histiocytic Sarcoma
01/2021
1Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma)
01/2021
1Brain Injuries (Brain Injury)
12/2020
1Brain Hypoxia-Ischemia (Hypoxia Ischemia, Brain)
12/2020
1Blast Crisis (Blast Phase)
11/2020
1African Trypanosomiasis (Nagana)
01/2020

Drug/Important Bio-Agent (IBA)

9RNA (Ribonucleic Acid)IBA
01/2023 - 01/2018
8DNA (Deoxyribonucleic Acid)IBA
01/2023 - 01/2015
7Imatinib Mesylate (Gleevec)FDA Link
01/2022 - 01/2003
6Phosphotransferases (Kinase)IBA
01/2022 - 01/2003
5Biomarkers (Surrogate Marker)IBA
01/2024 - 01/2017
4Phenobarbital (Luminal)FDA Link
02/2022 - 01/2022
4Proteins (Proteins, Gene)FDA Link
01/2020 - 04/2015
3LipidsIBA
06/2022 - 10/2021
3Anaplastic Lymphoma KinaseIBA
01/2021 - 02/2018
2ErbB Receptors (EGF Receptor)IBA
01/2023 - 01/2019
2Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
01/2022 - 11/2021
2Uric Acid (Urate)IBA
01/2022 - 01/2021
2Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA
11/2021 - 09/2015
2larotrectinibIBA
11/2021 - 01/2020
2EnzymesIBA
01/2021 - 01/2018
2Nuclear Proteins (Protein, Nuclear)IBA
04/2020 - 12/2018
2Keratins (Keratin)IBA
01/2020 - 01/2019
2Growth InhibitorsIBA
01/2020 - 01/2020
2ChromatinIBA
01/2019 - 10/2015
2Tyrosine Kinase InhibitorsIBA
10/2017 - 09/2007
1Tretinoin (Retinoic Acid)FDA LinkGeneric
05/2024
1Complement Receptors (Complement Receptor)IBA
12/2023
1Complement System Proteins (Complement)IBA
12/2023
1selpercatinibIBA
09/2023
1GenieIBA
09/2023
1Hematoxylin (Haematoxylon)IBA
01/2023
1Protein Isoforms (Isoforms)IBA
01/2023
1Eosine Yellowish-(YS) (Eosin)IBA
01/2023
1Ephrin-B1 (Ephrin B1)IBA
12/2022
1Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA
12/2022
1trametinibIBA
12/2022
1CholesterolIBA
06/2022
1oxidized low density lipoproteinIBA
06/2022
1T-Cell Antigen Receptors (T-Cell Receptor)IBA
04/2022
1CalciumIBA
01/2022
1CeramidesIBA
01/2022
1NucleotidesIBA
12/2021
1tyrosine receptor (receptor, tyrosine)IBA
11/2021
1Xanthine OxidaseIBA
01/2021
1Platelet-Derived Growth Factor beta Receptor (Receptor, Platelet Derived Growth Factor beta)IBA
01/2021
1Mitogen-Activated Protein KinasesIBA
01/2021
1Anticonvulsants (Antiepileptic Drugs)IBA
12/2020

Therapy/Procedure

21Therapeutics
11/2023 - 05/2009
6Drug Therapy (Chemotherapy)
05/2024 - 07/2012
5Carotid Endarterectomy
09/2023 - 01/2022
2Immunotherapy
12/2022 - 01/2020
2Endarterectomy (Thromboendarterectomy)
01/2022 - 01/2022
1Induction Chemotherapy
05/2024
1Time-to-Treatment
01/2023
1Induced Hypothermia
12/2020